Skip to content
Lower risk Drug recall · FDA · Published November 30, 2012

West-Ward Carisoprodol Recall: Labeling Error for Controlled Substance

West-Ward recalls Carisoprodol 350 mg tablets due to missing C-IV imprint. Check your bottle's lot number and label for compliance details.

🇺🇸 FDA recall #D-201-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling Carisoprodol Tablets, USP, 350 mg because the bottles lack the required "C-IV" controlled substance imprint on the label. This labeling error occurred because the product was distributed after the June 11, 2012 deadline for relabeling following a DEA final rule published in December 2011. The recall affects 1,763 bottles distributed nationwide. Read more at govinfonow.com/recall/48470-west-ward-pharmaceutical-corp-recalls-carisoprodol-tablets-usp-350-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/48470-west-ward-pharmaceutical-corp-recalls-carisoprodol-tablets-usp-350-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-201-2013

Cite this page

“West-Ward Carisoprodol Recall: Labeling Error for Controlled Substance.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48470-west-ward-pharmaceutical-corp-recalls-carisoprodol-tablets-usp-350-mg. Based on FDA recall #D-201-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-201-2013%22&limit=1).

The FDA announced on November 30, 2012, that West-Ward Pharmaceutical Corp. is recalling Carisoprodol Tablets, USP, 350 mg because the labeling lacked the required "C-IV" imprint for a controlled substance. The agency stated the recall addresses a failure to relabel products distributed after the June 11, 2012 deadline.

How to tell if you have it

  • Brand: West-Ward Pharmaceutical
  • Product: Carisoprodol Tablets 350 mg
  • NDC: 0143-1176-01
  • Lot #: 69160A
  • Quantity: 1763 bottles

The hazard

The product is a schedule IV (C-IV) controlled substance that was distributed without the required "C-IV" imprint on the label. This omission occurred because the product was not relabeled in compliance with a DEA final rule published on December 12, 2011.

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Wells Pharma Fentanyl Citrate Solution Recall (April 1, 2026).

How to tell if you have this one

Check your bottle of Carisoprodol Tablets, USP, 350 mg manufactured by West-Ward Pharmaceutical Corp. Look for NDC 0143-1176-01 and Lot # 69160A. Verify if the label is missing the "C-IV" imprint that should be present on products distributed after June 11, 2012.

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Nov 30, 201212. FDA classified it Class III: Mar 15, 201323. Published in FDA’s Enforcement Report: Mar 27, 201334. FDA terminated the recall: Dec 18, 2014420122014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-201-2013 (November 30, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-201-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA